Carlsbad, CA 1/10/08—Invitrogen has definitively agreed to acquire CellzDirect, a provider of hepatocyte-based primary cell products and services, for $57 million in cash. Hepatocyte-based primary cells are used in predicting the effect of a drug on enzymatic metabolism in the liver. “CellzDirect’s high-value products and services will greatly complement Invitrogen’s market-leading portfolio of complete cell […]
Hanau, Germany 12/11/07—Elemental analyzer firm Elementar Analysensysteme has acquired the former GV Instruments gas isotope ratio (IR) MS product line from Thermo Fisher Scientific. Last year, Thermo Fisher Scientific was ordered to divest the GV Instruments business by the UK’s Competition Commission (see IBO 5/31/07). Isoprime, a new subsidiary of Elementar Analysensysteme, will continue to […]
San Diego, CA 12/21/0—-Illumina has announced that the US Patent and Trademark Office (USPTO) will reexamine four of the five patents (US Patent Nos. 5,545,531; 5,795,716; 6,355,432 and 6,646,243) that are the subject of Affymetrix’s patent infringement suit against the company. In March, a jury ruled in favor of Affymetrix, finding that Illumina infringed or […]
Wilmington, DE 12/13/07—According to documents filed with the US District Court for the District of Delaware, the US Patent and Trademark Office (USPTO) has agreed to Thermo Fisher Scientific’s request to reexamine US Patent No. 4,963,736 (“Mass Spectrometer and Method Improved Ion Transmission”), held by MDS and licensed to Applera/Applied Biosystems. The patent is the […]
Waltham, MA 12/20/07—Thermo Fisher Scientific has purchased La-Pha-Pack, a provider of chromatography consumables and accessories. Based in Langerwehe, Germany, La-Pha-Pack has revenues of approximately $25 million. “This acquisition will significantly strengthen our chromatography offering in Europe by complementing our existing specialty brand, Chromacol, which is manufactured in the UK,” said Thermo Fisher Scientific President and […]
Waltham, MA 12/19/07; Fort Lauderdale, FL 12/19/07—PerkinElmer has definitively agreed to acquire Pediatrix Medical Group’s newborn metabolic screening business and its StepOne newborn screening product for cash. Pediatrix’s newborn screening laboratories provide neonatal screening and collaborative services to hospitals, medical groups, five states (Maryland, Mississippi, Louisiana, Nebraska, Pennsylvania) and the District of Columbia. The business […]
New York, NY 12/19/07—Enzo Biochem’s Life Sciences subsidiary has signed a letter of intent to purchase 10 P’s BVBA, a Belgium-based distributor of life science products that serves the Benelux countries. Financial terms were not disclosed. “10 P’s will not only provide us with the opportunity to improve and expand relationships with the end-users of […]
Santa Clara CA 12/18/07—Affymetrix has agreed to acquire USB, a manufacturer of molecular biology and biochemical reagents, for approximately $75 million in cash. Based in Cleveland, Ohio, USB offers three major product lines: molecular biology enzymes and kits, biochemical reagents and products for membrane protein research. “The integration of USB’s biochemical reagents with Affymetrix’s current […]
Billerica, MA 12/3/07—Bruker BioSciences has entered into a definitive agreement to acquire sister company Bruker BioSpin in a transaction valued at $914 million. Bruker BioSciences will offer $388 million in cash and 57.5 million shares, which are valued at $528 million according to the 10-day average closing price as of November 28. As a result […]
Holliston, MA 12/3/07 and 12/14/07; Washington, DC 12/12/07—Harvard Bioscience has rejected an acquisition offer from Skystone Advisors. On December 12, Skystone, which holds 15.4% of Harvard Bioscience’s stock, made an offer to acquire the company and take it private. In a letter to the Harvard Bioscience Board, Skystone stated it would acquire all the outstanding […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
